Net profit of RPG Life Sciences rose 32.01% to Rs 34.93 crore in the quarter ended December 2024 as against Rs 26.46 crore during the previous quarter ended December 2023. Sales rose 12.37% to Rs 172.71 crore in the quarter ended December 2024 as against Rs 153.70 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 172.71 | 153.70 | 12 |
| OPM % | 28.46 | 24.66 | - |
| PBDT | 52.35 | 39.68 | 32 |
| PBT | 46.89 | 35.54 | 32 |
| NP | 34.93 | 26.46 | 32 |